Lymphadenopathy subsequent to Covishield (ChAdOx1 nCoV-19) Corona virus vaccine: ultrasound findings and clinical implications

INTRODUCTION: Post anti-COVID-19 vaccine lymphadenopathies have been recently described in literature, from different parts of the world. Although there have been studies on lymphadenopathy following mRNA vaccines, there is a paucity of studies on lymphadenopathy following inactivated viral vaccines...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahoo, Soumya Swaroop, Kaur, Navdeep, Kaur, Amandeep, Garg, Shivane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Drug safety of the currently available COVID-19 treatments
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482933/
https://www.ncbi.nlm.nih.gov/pubmed/36133302
http://dx.doi.org/10.1177/25151355221124018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482933/
https://www.ncbi.nlm.nih.gov/pubmed/36133302
http://dx.doi.org/10.1177/25151355221124018

Ejemplares similares